Ben Haynor
Stock Analyst at Alliance Global Partners
(1.11)
# 2,619
Out of 4,413 analysts
34
Total ratings
36.36%
Success rate
-19.36%
Average return
Main Sectors:
16 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ICCM IceCure Medical | Maintains: Buy | $1.9 → $2.9 | $1.17 | +147.86% | 3 | Mar 20, 2024 | |
PROF Profound Medical | Maintains: Buy | $13 → $11 | $7.45 | +44.97% | 3 | Mar 11, 2024 | |
EVGN Evogene | Initiates: Buy | $1.85 | $0.72 | +158.52% | 1 | Oct 2, 2023 | |
NNOX Nano-X Imaging | Initiates: Buy | $15 | $9.16 | +58.30% | 1 | Sep 8, 2023 | |
AWH Aspira Women's Health | Initiates: Buy | $5.6 | $3.26 | +72.04% | 1 | Aug 22, 2023 | |
NMTC NeuroOne Medical Technologies | Maintains: Buy | $3.25 → $2.2 | $1.16 | +89.66% | 1 | Aug 15, 2023 | |
DRIO DarioHealth | Maintains: Buy | $5.45 → $4.1 | $1.46 | +180.82% | 3 | Aug 11, 2023 | |
TTOO T2 Biosystems | Maintains: Neutral | $12 → $7 | $3.00 | +133.33% | 7 | Jul 13, 2023 | |
BEAT HeartBeam | Maintains: Buy | $10 → $5.55 | $2.16 | +156.47% | 2 | May 19, 2023 | |
NSPR InspireMD | Maintains: Buy | $5.15 → $4.75 | $1.95 | +143.09% | 3 | May 17, 2023 | |
SRTS Sensus Healthcare | Maintains: Buy | $15 → $7 | $3.61 | +93.91% | 3 | May 4, 2023 | |
CLGN CollPlant Biotechnologies | Initiates: Buy | $23 | $5.78 | +293.60% | 1 | Feb 17, 2023 | |
MYO Myomo | Maintains: Buy | $10 → $6.7 | $3.53 | +89.80% | 2 | Jul 8, 2022 | |
RSLS ReShape Lifesciences | Maintains: Buy | $275 → $233 | $0.17 | +139,121.56% | 1 | May 26, 2022 | |
OPGN OpGen | Maintains: Buy | n/a | $0.41 | - | 1 | Mar 2, 2021 | |
IBIO iBio, Inc. | Initiates: Buy | $1,375 | $1.85 | +74,224.32% | 1 | Jun 26, 2020 |
IceCure Medical
Mar 20, 2024
Maintains: Buy
Price Target: $1.9 → $2.9
Current: $1.17
Upside: +147.86%
Profound Medical
Mar 11, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $7.45
Upside: +44.97%
Evogene
Oct 2, 2023
Initiates: Buy
Price Target: $1.85
Current: $0.72
Upside: +158.52%
Nano-X Imaging
Sep 8, 2023
Initiates: Buy
Price Target: $15
Current: $9.16
Upside: +58.30%
Aspira Women's Health
Aug 22, 2023
Initiates: Buy
Price Target: $5.6
Current: $3.26
Upside: +72.04%
NeuroOne Medical Technologies
Aug 15, 2023
Maintains: Buy
Price Target: $3.25 → $2.2
Current: $1.16
Upside: +89.66%
DarioHealth
Aug 11, 2023
Maintains: Buy
Price Target: $5.45 → $4.1
Current: $1.46
Upside: +180.82%
T2 Biosystems
Jul 13, 2023
Maintains: Neutral
Price Target: $12 → $7
Current: $3.00
Upside: +133.33%
HeartBeam
May 19, 2023
Maintains: Buy
Price Target: $10 → $5.55
Current: $2.16
Upside: +156.47%
InspireMD
May 17, 2023
Maintains: Buy
Price Target: $5.15 → $4.75
Current: $1.95
Upside: +143.09%
Sensus Healthcare
May 4, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $3.61
Upside: +93.91%
CollPlant Biotechnologies
Feb 17, 2023
Initiates: Buy
Price Target: $23
Current: $5.78
Upside: +293.60%
Myomo
Jul 8, 2022
Maintains: Buy
Price Target: $10 → $6.7
Current: $3.53
Upside: +89.80%
ReShape Lifesciences
May 26, 2022
Maintains: Buy
Price Target: $275 → $233
Current: $0.17
Upside: +139,121.56%
OpGen
Mar 2, 2021
Maintains: Buy
Price Target: n/a
Current: $0.41
Upside: -
iBio, Inc.
Jun 26, 2020
Initiates: Buy
Price Target: $1,375
Current: $1.85
Upside: +74,224.32%